1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Ontario >
  6. Rubicon Acquires Impopharma Canada

M&A Deal Summary

Rubicon Acquires Impopharma Canada

On January 7, 2020, Rubicon acquired life science company Impopharma Canada

Acquisition Highlights
  • This is Rubicon’s 1st transaction in the Life Science sector.
  • This is Rubicon’s 1st transaction in Canada.
  • This is Rubicon’s 1st transaction in Ontario.

M&A Deal Summary
Date 2020-01-07
Target Impopharma Canada
Sector Life Science
Buyer(s) Rubicon
Deal Type Add-on Acquisition

Target

Impopharma Canada

Concord, Ontario, Canada
Impopharma Canada Ltd. is a specialty pharmaceutical company offers comprehensive drug product formulation and process development, as well as wide-ranging analytical testing services to the pharmaceutical industry, specializing in nasal and pulmonary drug products. Impopharma Canada is based in Concord, Ontario.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Rubicon

Mumbai, India
Category Company
Founded 1999
Sector Life Science
DESCRIPTION

Rubicon is a knowledge process outsourcing (KPO) company that provides contract research services for pharmaceutical companies worldwide. It specialises in formulation and drug delivery technologies for controlled release and generic plus products. It also develops novel products for innovator and specialty companies. Rubicon was founded in 1999 and is based in Mumbai, Maharashtra.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2020 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal